Search

Your search keyword '"Ajeet Gajra"' showing total 282 results

Search Constraints

Start Over You searched for: Author "Ajeet Gajra" Remove constraint Author: "Ajeet Gajra"
282 results on '"Ajeet Gajra"'

Search Results

1. US Clinical Practice Experience with Eculizumab in Myasthenia Gravis: Acute Clinical Events and Healthcare Resource Utilization

2. Simplifying informed consent as a universal precaution

4. Impact of social determinants of health on cancer care: a survey of community oncologists

5. nab-Paclitaxel/Carboplatin in Vulnerable Populations With Advanced Non-Small Cell Lung Cancer: Pooled Analysis

6. nab-Paclitaxel-Based Therapy in Underserved Patient Populations: The ABOUND.70+ Study in Elderly Patients With Advanced NSCLC

7. nab-Paclitaxel–Based Therapy in Underserved Patient Populations: The ABOUND.PS2 Study in Patients With NSCLC and a Performance Status of 2

8. Current Status of New Anticoagulants in the Management of Venous Thromboembolism

9. PET Response-Guided Treatment of Hodgkin's Lymphoma: A Review of the Evidence and Active Clinical Trials

10. Reducing Avoidable Emergency Visits and Hospitalizations With Patient Risk-Based Prescriptive Analytics: A Quality Improvement Project at an Oncology Care Model Practice

11. Characteristics, Treatment, and Outcomes of Real-World Talazoparib-Treated Patients With Germline BRCA-Mutated Advanced HER2-Negative Breast Cancer

12. Treatment Patterns of Real-World Patients with TRK Fusion Cancer Treated by US Community Oncologists

13. Low Rate of Clinically Evident Extravascular Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with a Complement C5 Inhibitor: Results from a Large, Multicenter, US Real-World Study

14. The Use and Knowledge of Validated Geriatric Assessment Instruments Among US Community Oncologists

20. Impact of Augmented Intelligence on Utilization of Palliative Care Services in a Real-World Oncology Setting

21. Augmented intelligence to predict 30-day mortality in patients with cancer

27. Timing of NTRK Gene Fusion Testing and Treatment Modifications Following TRK Fusion Status Among US Oncologists Treating TRK Fusion Cancer

28. Older Patients with Lung Cancer: a Summary of Seminal Contributions to Optimal Patient Care

29. Barriers to Chimeric Antigen Receptor T-Cell (CAR-T) Therapies in Clinical Practice

30. Physician treatment of metastatic triple-negative breast cancer in the immuno-oncology era: a discrete choice experiment

31. Use of Real-World Evidence to Support FDA Approval of Oncology Drugs

32. The association between social support and chemotherapy-related toxicity in older patients with cancer

33. Association between a cognitive screening test and severe chemotherapy toxicity in older adults with cancer

34. Real-world incidence and cost of pneumonitis post-chemoradiotherapy for Stage III non-small-cell lung cancer

35. Heterogeneous Versus Homogeneous Radiation Dose Calculations of Twice-Daily Fractionation in Small Cell Lung Carcinoma

36. Impact of social determinants of health on cancer care: a survey of community oncologists

38. Real-world clinical outcomes with enasidenib in relapsed or refractory acute myeloid leukemia

41. Biosimilars And Follow-On Products

42. Risk Factors for Hospitalizations Among Older Adults with Gastrointestinal Cancers

43. A Letter in Support of Real-World RECIST

44. Frailty assessment predicts toxicity during first cycle chemotherapy for advanced lung cancer regardless of chronologic age

45. Predictors of Unplanned Hospitalizations Among Older Adults Receiving Cancer Chemotherapy

46. Impact of an augmented intelligence-based tool upon the timeliness of referrals to palliative care and hospice in patients with advanced cancer in the real-world setting

47. Real-world (RW) treatment patterns and comparative effectiveness of Bruton tyrosine kinase inhibitors (BTKi) in patients (pts) with mantle cell lymphoma (MCL)

48. Real-world erythropoiesis-stimulating agent (ESA) treatment patterns and outcomes among U.S. patients with lower-risk myelodysplastic syndromes (LR-MDS)

49. Mental health care for oncology patients in community settings

50. Biosimilars And Follow-On Products

Catalog

Books, media, physical & digital resources